Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.49 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5081835 | 1.00 | ZDHHC20 (0.49) | ZDHHC20ZDHHC2DNM1TSHRCYP1A2 | |
| SCHEMBL11023925 | 0.93 | ZDHHC20 (0.46) | ZDHHC20ZDHHC2DNM1TSHRCYP1A2 | |
| SCHEMBL10646289 | 0.91 | KCNH2 (0.47) | ZDHHC20ZDHHC2DNM1KCNH2 | |
| SCHEMBL240366 | 0.90 | TSHR (0.43) | ZDHHC20ZDHHC2TSHRCYP1A2MAPK1 | |
| SCHEMBL19497014 | 0.88 | TSHR (0.42) | ZDHHC20ZDHHC2TSHRCYP1A2MAPK1 | |
| SCHEMBL19999960 | 0.85 | TSHR (0.43) | ZDHHC20ZDHHC2TSHRCYP1A2MAPK1 | |
| SCHEMBL31264715 | 0.83 | CYP1A2 (0.41) | ZDHHC20ZDHHC2CYP1A2MAPK1KCNH2 | |
| SCHEMBL11143458 | 0.82 | ZDHHC20 (0.51) | ZDHHC20ZDHHC2DNM1TSHRCYP1A2 | |
| SCHEMBL4173370 | 0.82 | CYP1A2 (0.48) | ZDHHC20ZDHHC2TSHRCYP1A2MAPK1 | |
| SCHEMBL21467473 | 0.81 | KCNH2 (0.44) | ZDHHC20ZDHHC2TSHRCYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023942-A1 | Method for Producing Bi-Functional Ammonium Nitriles | CLARIANT PRODUKTE (DEUTSCHALND) GMBH (DE) | 2009-01-22 | — | — | US | claimed |
| EP-1856034-A1 | METHOD FOR PRODUCING BIFUNCTIONAL AMMONIUM NITRILES | Clariant Produkte (Deutschland) GmbH (DE) | 2007-11-21 | — | — | EP | claimed |
| WO-2006092247-A1 | METHOD FOR PRODUCING BIFUNCTIONAL AMMONIUM NITRILES | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2006-09-08 | — | — | WO | claimed |
| US-20090023942-A1 | Method for Producing Bi-Functional Ammonium Nitriles | CLARIANT PRODUKTE (DEUTSCHALND) GMBH (DE) | 2009-01-22 | — | — | US | disclosed |
| EP-1487955-B1 | AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2008-05-21 | — | — | EP | disclosed |
| US-7015185-B2 | Ammonium nitriles and the use thereof as hydrophobic bleaching activators | CLARIANT GMBH (DE) | 2006-03-21 | — | — | US | disclosed |
| US-20040266644-A1 | Ammonium nitriles and the use thereof as hydrophobic bleaching activators | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-12-30 | — | — | US | disclosed |
| EP-1487955-A1 | AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS | Clariant GmbH (DE) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003078561-A1 | AMMONIUM NITRILES AND THE USE THEREOF AS HYDROPHOBIC BLEACHING ACTIVATORS | CLARIANT GMBH (DE) | 2003-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023942-A1 | Method for Producing Bi-Functional Ammonium Nitriles | DBF4, AADAC, NAAA | ZDHHC20 2965/4885ZDHHC2 2829/4885DNM1 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.